Nitroxoline Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Suppressing STAT3-AKT-MTOR Survival Signaling. [PDF]
Gong EY +8 more
europepmc +1 more source
AI-driven digital twins for bone tumors: personalizing immunoradiotherapy and drug-based radiosensitization. [PDF]
Tong J, Chen D, Chen H, Yu T.
europepmc +1 more source
Multicenter Prospective Phase II Study of Induction Therapy With Pembrolizumab, Cisplatin, and Fluorouracil in Patients With Locally Advanced Head and Neck Cancer. [PDF]
Pokataev I +19 more
europepmc +1 more source
Targeting CLIC6 with theaflavin enhances radiotherapy sensitivity in ER<sup>+</sup>/HER2<sup>-</sup> breast cancer. [PDF]
Suo M, Liu L, She T, Chen C.
europepmc +1 more source
Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma. [PDF]
Skeie BS +6 more
europepmc +1 more source
Long-term outcomes of 40 Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL. [PDF]
Yoon SE +5 more
europepmc +1 more source
Exploring the role of hydrogen peroxide in the immune microenvironment of hypoxic tumors. [PDF]
Geirnaert F +5 more
europepmc +1 more source
A pH-responsive layered double hydroxide nanoradiosensitizer for bone metastasis tumor. [PDF]
Yang C +6 more
europepmc +1 more source
Targeting glutathione metabolism for tumor radiosensitization (Review). [PDF]
Xu H, Du M, Liang X, Xiao X, Chen Z.
europepmc +1 more source

